Functional protein microarrays for parallel characterisation of p53 mutants
- 22 June 2004
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 4 (7) , 1950-1958
- https://doi.org/10.1002/pmic.200300722
Abstract
Understanding the way in which single nucleotide polymorphisms and mutations in the human genome result in individual susceptibility to disease is a major goal in the postgenomic era. Such knowledge should accelerate the development of personalised medicine in which drug treatment can specifically match an individual's genotype. High-throughput DNA sequencing is generating the initial information required, but new technologies are required that can rapidly characterise the phenotypic effects of the identified polymorphisms. For example, many thousands of allelic variants of the p53 gene have been described and are responsible for more than 50% of cancers, however few of the protein products have been functionally characterised. Here we have quantified in parallel the effects of mutations and polymorphisms on the DNA-binding function of the p53 oncoprotein using a protein microarray, allowing their subclassification according to functional effect. Protein-protein interactions between p53 variants and (i) a regulatory oncoprotein, (ii) a regulatory kinase resulting in on-chip phosphorylation, are also described, suggesting the more general utility of this high-throughput assay format.Keywords
This publication has 38 references indexed in Scilit:
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNature Genetics, 2003
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002
- Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compoundNature Medicine, 2002
- Relative frequency and morphology of cancers in carriers of germline TP53 mutationsOncogene, 2001
- Protein−DNA Binding Correlates with Structural Thermostability for the Full-Length Human p53 ProteinBiochemistry, 2001
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- MDM2 — master regulator of the p53 tumor suppressor proteinGene, 2000
- Pharmacological Rescue of Mutant p53 Conformation and FunctionScience, 1999
- Characterization of p53 oligomerization domain mutations isolated from Li–Fraumeni and Li–Fraumeni like family membersOncogene, 1998
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976